SEARCH

SEARCH BY CITATION

References

  • Allavena, P. & Mantovani, A. (2012) Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment. Clinical & Experimental Immunology, 167, 195205.
  • Altman, D.G., De Stavola, B.L., Love, S.B. & Stepniewska, K.A. (1995) Review of survival analyses published in cancer journals. British Journal of Cancer, 72, 511518.
  • Andjelic, B., Mihaljevic, B., Todorovic, M., Bila, J., Jakovic, L. & Jovanovic, M.P. (2012) The number of lymphoma-associated macrophages in tumor tissue is an independent prognostic factor in patients with follicular lymphoma. Applied Immunohistochemistry & Molecular Morphology, 20, 4146.
  • Azambuja, D., Natkunam, Y., Biasoli, I., Lossos, I.S., Anderson, M.W., Morais, J.C. & Spector, N. (2012) Lack of association of tumor-associated macrophages with clinical outcome in patients with classical Hodgkin's lymphoma. Annals of Oncology, 23, 736742.
  • Bertoni, F., Rinaldi, A., Zucca, E. & Cavalli, F. (2006) Update on the molecular biology of mantle cell lymphoma. Hematological Oncology, 24, 2227.
  • Burger, J.A. & Ford, R.J. (2011) The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapies. Seminars in Cancer Biology, 21, 308312.
  • Byers, R.J., Sakhinia, E., Joseph, P., Glennie, C., Hoyland, J.A., Menasce, L.P., Radford, J.A. & Illidge, T. (2008) Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood, 111, 47644770.
  • Cai, Q.C., Liao, H., Lin, S.X., Xia, Y., Wang, X.X., Gao, Y., Lin, Z.X., Lu, J.B. & Huang, H.Q. (2012) High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma. Medical Oncology, 29, 23172322.
  • Canioni, D., Salles, G., Mounier, N., Brousse, N., Keuppens, M., Morchhauser, F., Lamy, T., Sonet, A., Rousselet, M.C., Foussard, C. & Xerri, L. (2008) High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. Journal of Clinical Oncology, 26, 440446.
  • Cheson, B.D., Pfistner, B., Juweid, M.E., Gascoyne, R.D., Specht, L., Horning, S.J., Coiffier, B., Fisher, R.I., Hagenbeek, A., Zucca, E., Rosen, S.T., Stroobants, S., Lister, T.A., Hoppe, R.T., Dreyling, M., Tobinai, K., Vose, J.M., Connors, J.M., Federico, M. & Diehl, V. (2007) Revised response criteria for malignant lymphoma. Journal of Clinical Oncology, 25, 579586.
  • Conconi, A., Franceschetti, S., Lobetti-Bodoni, C., Stathis, A., Margiotta-Casaluci, G., Ramponi, A., Mazzucchelli, L., Bertoni, F., Ghielmini, M., Gaidano, G., Cavalli, F. & Zucca, E. (2013) Risk factors of central nervous system relapse in mantle cell lymphoma. Leukemia & Lymphoma, doi: 10.3109/10428194.2013.767454.
  • Coupland, S.E. (2011) The challenge of the microenvironment in B-cell lymphomas. Histopathology, 58, 6980.
  • Cox, D.R. (1972) Regression models and life tables. Journal of the Royal Statistical Society. Series B (Methodological), 34, 187220.
  • Dave, S.S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R.D., Chan, W.C., Fisher, R.I., Braziel, R.M., Rimsza, L.M., Grogan, T.M., Miller, T.P., LeBlanc, M., Greiner, T.C., Weisenburger, D.D., Lynch, J.C., Vose, J., Armitage, J.O., Smeland, E.B., Kvaloy, S., Holte, H., Delabie, J., Connors, J.M., Lansdorp, P.M., Ouyang, Q., Lister, T.A., Davies, A.J., Norton, A.J., Muller-Hermelink, H.K., Ott, G., Campo, E., Montserrat, E., Wilson, W.H., Jaffe, E.S., Simon, R., Yang, L., Powell, J., Zhao, H., Goldschmidt, N., Chiorazzi, M. & Staudt, L.M. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. The New England Journal of Medicine, 351, 21592169.
  • Epron, G., Ame-Thomas, P., Le Priol, J., Pangault, C., Dulong, J., Lamy, T., Fest, T. & Tarte, K. (2012) Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling. Leukemia, 26, 139148.
  • Farinha, P., Masoudi, H., Skinnider, B.F., Shumansky, K., Spinelli, J.J., Gill, K., Klasa, R., Voss, N., Connors, J.M. & Gascoyne, R.D. (2005) Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood, 106, 21692174.
  • Geisler, C.H., Kolstad, A., Laurell, A., Raty, R., Jerkeman, M., Eriksson, M., Nordstrom, M., Kimby, E., Boesen, A.M., Nilsson-Ehle, H., Kuittinen, O., Lauritzsen, G.F., Ralfkiaer, E., Ehinger, M., Sundstrom, C., Delabie, J., Karjalainen-Lindsberg, M.L., Brown, P. & Elonen, E. (2010) The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood, 115, 15301533.
  • Ghielmini, M. & Zucca, E. (2009) How I treat mantle cell lymphoma. Blood, 114, 14691476.
  • Greaves, P., Clear, A., Coutinho, R., Wilson, A., Matthews, J., Owen, A., Shanyinde, M., Lister, T.A., Calaminici, M. & Gribben, J.G. (2013) Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical hodgkin lymphoma is predictive of outcome. Journal of Clinical Oncology, 31, 256262.
  • Guilloton, F., Caron, G., Menard, C., Pangault, C., Ame-Thomas, P., Dulong, J., De Vos, J., Rossille, D., Henry, C., Lamy, T., Fouquet, O., Fest, T. & Tarte, K. (2012) Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. Blood, 119, 25562567.
  • Hasselblom, S., Hansson, U., Sigurdardottir, M., Nilsson-Ehle, H., Ridell, B. & Andersson, P.O. (2008) Expression of CD68+ tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis. Pathology International, 58, 529532.
  • Hoster, E., Dreyling, M., Klapper, W., Gisselbrecht, C., van Hoof, A., Kluin-Nelemans, H.C., Pfreundschuh, M., Reiser, M., Metzner, B., Einsele, H., Peter, N., Jung, W., Wormann, B., Ludwig, W.D., Duhrsen, U., Eimermacher, H., Wandt, H., Hasford, J., Hiddemann, W. & Unterhalt, M. (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood, 111, 558565.
  • Ishii, H., Takahara, M., Nagato, T., Kis, L.L., Nagy, N., Kishibe, K., Harabuchi, Y. & Klein, E. (2012) Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15. International Journal of Cancer, 130, 4858.
  • de Jong, D., Koster, A., Hagenbeek, A., Raemaekers, J., Veldhuizen, D., Heisterkamp, S., de Boer, J.P. & van Glabbeke, M. (2009) Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica, 94, 7077.
  • Kalbfleisch, J.D. & Prentice, R.L. (1980) The Statistical Analysis of Failure Time Data. John Wiley & Sons, New York.
  • Kaplan, E.L. & Meier, P. (1958) Nonparametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457481.
  • Kelley, T., Beck, R., Absi, A., Jin, T., Pohlman, B. & Hsi, E. (2007) Biologic predictors in follicular lymphoma: importance of markers of immune response. Leukemia & Lymphoma, 48, 24032411.
  • Koh, Y.W., Kang, H.J., Park, C., Yoon, D.H., Kim, S., Suh, C., Go, H., Kim, J.E., Kim, C.W. & Huh, J. (2012) The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages. The Oncologist, 17, 871880.
  • Lenz, G., Wright, G., Dave, S.S., Xiao, W., Powell, J., Zhao, H., Xu, W., Tan, B., Goldschmidt, N., Iqbal, J., Vose, J., Bast, M., Fu, K., Weisenburger, D.D., Greiner, T.C., Armitage, J.O., Kyle, A., May, L., Gascoyne, R.D., Connors, J.M., Troen, G., Holte, H., Kvaloy, S., Dierickx, D., Verhoef, G., Delabie, J., Smeland, E.B., Jares, P., Martinez, A., Lopez-Guillermo, A., Montserrat, E., Campo, E., Braziel, R.M., Miller, T.P., Rimsza, L.M., Cook, J.R., Pohlman, B., Sweetenham, J., Tubbs, R.R., Fisher, R.I., Hartmann, E., Rosenwald, A., Ott, G., Muller-Hermelink, H.K., Wrench, D., Lister, T.A., Jaffe, E.S., Wilson, W.H., Chan, W.C. & Staudt, L.M. (2008) Stromal gene signatures in large-B-cell lymphomas. The New England Journal of Medicine, 359, 23132323.
  • Li, Z.M., Huang, J.J., Xia, Y., Sun, J., Huang, Y., Wang, Y., Zhu, Y.J., Li, Y.J., Zhao, W., Wei, W.X., Lin, T.Y., Huang, H.Q. & Jiang, W.Q. (2012) Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. PLoS ONE, 7, e41658.
  • Martin, P. & Leonard, J. (2011) Is there a role for “watch and wait” in patients with mantle cell lymphoma? Seminars in Hematology, 48, 189193.
  • Martin, P., Chadburn, A., Christos, P., Weil, K., Furman, R.R., Ruan, J., Elstrom, R., Niesvizky, R., Ely, S., Diliberto, M., Melnick, A., Knowles, D.M., Chen-Kiang, S., Coleman, M. & Leonard, J.P. (2009) Outcome of deferred initial therapy in mantle-cell lymphoma. Journal of Clinical Oncology, 27, 12091213.
  • Mueller, C.G., Boix, C., Kwan, W.H., Daussy, C., Fournier, E., Fridman, W.H. & Molina, T.J. (2007) Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation. Journal of Leukocyte Biology, 82, 567575.
  • Nygren, L., Baumgartner Wennerholm, S., Klimkowska, M., Christensson, B., Kimby, E. & Sander, B. (2012) Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood, 119, 42154223.
  • Perez-Galan, P., Dreyling, M. & Wiestner, A. (2011) Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood, 117, 2638.
  • Perry, J.A., Thamm, D.H., Eickhoff, J., Avery, A.C. & Dow, S.W. (2011) Increased monocyte chemotactic protein-1 concentration and monocyte count independently associate with a poor prognosis in dogs with lymphoma. Veterinary and Comparative Oncology, 9, 5564.
  • Porrata, L.F., Ristow, K., Colgan, J.P., Habermann, T.M., Witzig, T.E., Inwards, D.J., Ansell, S.M., Micallef, I.N., Johnston, P.B., Nowakowski, G.S., Thompson, C. & Markovic, S.N. (2012a) Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica, 97, 262269.
  • Porrata, L.F., Ristow, K., Habermann, T.M., Ozsan, N., Dogan, A., Macon, W., Colgan, J.P., Witzig, T.E., Inwards, D.J., Ansell, S.M., Micallef, I.N., Johnston, P.B., Nowakowski, G.S., Thompson, C. & Markovic, S.N. (2012b) Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma. Leukemia & Lymphoma, 53, 21592165.
  • Porrata, L.F., Ristow, K., Habermann, T.M., Witzig, T.E., Colgan, J.P., Inwards, D.J., Ansell, S.M., Micallef, I.N., Johnston, P.B., Nowakowski, G.S., Thompson, C. & Markovic, S.N. (2012c) Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma. British Journal of Haematology, 157, 321330.
  • Steidl, C., Lee, T., Shah, S.P., Farinha, P., Han, G., Nayar, T., Delaney, A., Jones, S.J., Iqbal, J., Weisenburger, D.D., Bast, M.A., Rosenwald, A., Muller-Hermelink, H.K., Rimsza, L.M., Campo, E., Delabie, J., Braziel, R.M., Cook, J.R., Tubbs, R.R., Jaffe, E.S., Lenz, G., Connors, J.M., Staudt, L.M., Chan, W.C. & Gascoyne, R.D. (2010) Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. The New England Journal of Medicine, 362, 875885.
  • Swerdlow, S.H., Campo, E., Seto, M. & Muller-Hermelink, H.K. (2008) Mantle cell lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. (ed. by S. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele & J.W. Vardiman), pp. 229232. IARC, Lyon.
  • Tadmor, T., Fell, R., Polliack, A. & Attias, D. (2012) Absolute monocytosis at diagnosis correlates with survival in diffuse large B-cell lymphoma-possible link with monocytic myeloid-derived suppressor cells. Hematological Oncology, 31, 325331.
  • Taskinen, M., Karjalainen-Lindsberg, M.L., Nyman, H., Eerola, L.M. & Leppa, S. (2007) A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone. Clinical Cancer Research, 13, 57845789.
  • The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. The New England Journal of Medicine, 329, 987994.
  • de Totero, D., Meazza, R., Capaia, M., Fabbi, M., Azzarone, B., Balleari, E., Gobbi, M., Cutrona, G., Ferrarini, M. & Ferrini, S. (2008) The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways. Blood, 111, 517524.
  • Valkovic, T., Duletic-Nacinovic, A., Stifter, S., Hasan, M., Hadzisejdic, I., Zombori, D., Grahovac, B. & Jonjic, N. (2010) Macrophage chemotactic protein-1 mRNA levels in non-Hodgkin lymphoma. Clinical and Experimental Medicine, 10, 229235.
  • Wada, N., Zaki, M.A., Hori, Y., Hashimoto, K., Tsukaguchi, M., Tatsumi, Y., Ishikawa, J., Tominaga, N., Sakoda, H., Take, H., Tsudo, M., Kuwayama, M., Morii, E. & Aozasa, K. (2012) Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group. Histopathology, 60, 313319.
  • Wahlin, B.E., Aggarwal, M., Montes-Moreno, S., Gonzalez, L.F., Roncador, G., Sanchez-Verde, L., Christensson, B., Sander, B. & Kimby, E. (2010) A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1–positive, regulatory, cytotoxic, and helper T cells and macrophages. Clinical Cancer Research, 16, 637650.
  • Wilcox, R.A., Wada, D.A., Ziesmer, S.C., Elsawa, S.F., Comfere, N.I., Dietz, A.B., Novak, A.J., Witzig, T.E., Feldman, A.L., Pittelkow, M.R. & Ansell, S.M. (2009) Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. Blood, 114, 29362944.
  • Wilcox, R.A., Ristow, K., Habermann, T.M., Inwards, D.J., Micallef, I.N., Johnston, P.B., Colgan, J.P., Nowakowski, G.S., Ansell, S.M., Witzig, T.E., Markovic, S.N. & Porrata, L. (2011) The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia, 25, 15021509.
  • Wilcox, R.A., Ristow, K., Habermann, T.M., Inwards, D.J., Micallef, I.N., Johnston, P.B., Colgan, J.P., Nowakowski, G.S., Ansell, S.M., Witzig, T.E., Markovic, S.N. & Porrata, L. (2012) The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma. Leukemia & Lymphoma, 53, 575580.
  • Zaki, M.A., Wada, N., Ikeda, J., Shibayama, H., Hashimoto, K., Yamagami, T., Tatsumi, Y., Tsukaguchi, M., Take, H., Tsudo, M., Morii, E. & Aozasa, K. (2011) Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma. Virchows Archiv, 459, 361366.
  • Zucca, E., Roggero, E., Pinotti, G., Pedrinis, E., Cappella, C., Venco, A. & Cavalli, F. (1995) Patterns of survival in mantle cell lymphoma. Annals of Oncology, 6, 257262.